{"id":6915,"date":"2015-09-18T15:14:47","date_gmt":"2015-09-18T15:14:47","guid":{"rendered":"\/?p=6915"},"modified":"2015-09-18T15:39:22","modified_gmt":"2015-09-18T15:39:22","slug":"tapimmune-inc-otcmktstpiv-gets-its-teeth-kicked-in","status":"publish","type":"post","link":"\/articles\/tapimmune-inc-otcmktstpiv-gets-its-teeth-kicked-in\/","title":{"rendered":"TapImmune Inc. (OTCMKTS:TPIV) Gets Its Teeth Kicked In"},"content":{"rendered":"\n<p><img loading=\"lazy\" decoding=\"async\" style=\"float: right;\" src=\"\/\/s.hotstocked.com\/hotstocked.com\/repository\/articles\/91\/91390\/fasdfas.png\" border=\"0\" width=\"446\" height=\"199\" \/>Yesterday, TapImmune Inc. (OTCMKTS:<a href=\"http:\/\/www.thehotpennystocks.com\/Stock-Quotes\/?stock=TPIV\">TPIV<\/a>) lost all the gains it had managed to make in the previous session before it had even made it halfway through the day. What gives? <\/p>\n<p>Well, to answer that question, a look at the company&#8217;s state of affairs is most assuredly in order. The press releases tend to be optimistic &ndash; and judging by the claims in them, the company is making actual progress with respect to its goal of putting a product out on the market.<\/p>\n<p><strong><a href=\"http:\/\/www.thehotpennystocks.com\/Stock-Quotes\/?stock=TPIV\">TPIV<\/a>&#8216;s <\/strong>financials don&#8217;t look half bad either, especially for a pharmaceutical OTC Markets company with no revenues:<\/p>\n<ul>\n<li>cash &#8211; $3.1 million<\/li>\n<li>current assets &#8211; $3.2 million<\/li>\n<li>current liabilities &#8211; $13 million<\/li>\n<li>loss from operations &#8211; $1.1 million<\/li>\n<\/ul>\n<p>Sure, that number next to &ldquo;liabilities&rdquo; seems awfully high. However, anyone willing to take a closer look at that will discover that most of said sum is due to derivative liabilities, and the company&#8217;s actual debt is not that staggering.<\/p>\n<p>It also bears noting that none of the debt currently outstanding seems to be of the investor-value-crushing-toxic-convertible variety. However, in this case, it&#8217;s not the <strong><a href=\"http:\/\/www.thehotpennystocks.com\/Stock-Quotes\/?stock=TPIV\">TPIV<\/a>&#8216;s <\/strong>present stock-issuance-related shenanigans that investors should be wary of &ndash; it&#8217;s the company&#8217;s past questionable funding decisions that could come back around and bite the unwary on the backside.<\/p>\n<p>Some time ago, a <strong><a href=\"http:\/\/www.thehotpennystocks.com\/Stock-Quotes\/?stock=TPIV\">TPIV<\/a> <\/strong>made a private placement and sold 12.3 million investment units at $0.20 a pop. Each of said units consisted of one share of <strong><a href=\"http:\/\/www.thehotpennystocks.com\/Stock-Quotes\/?stock=TPIV\">TPIV<\/a> <\/strong>common stock, as well as a varying number of warrants for the purchase of more stock at fixed prices.<\/p>\n<p>Although it did afford the company some breathing room by procuring $2.3 million worth of funds in cash, that move nonetheless caused quite a bit of dilution. Two months ago, said warrants were still the source of much grief, with 5 million warrants getting exercised to buy <strong><a href=\"http:\/\/www.thehotpennystocks.com\/Stock-Quotes\/?stock=TPIV\">TPIV<\/a> <\/strong>at $0.50 before the end of Q2 2015 alone. The first two months of Q3 saw a further 7.89 million warrants turn into shares at the even more ridiculous price of $0.20 apiece.<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" style=\"float: left;\" src=\"\/\/s.hotstocked.com\/hotstocked.com\/repository\/articles\/91\/91390\/fasdf.jpg\" border=\"0\" width=\"130\" height=\"87\" \/>Is it any wonder that the ticker is falling, when such grandiose opportunities for warrant holders to make a huge profit still exist?<\/p>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Yesterday, TapImmune Inc. (OTCMKTS:TPIV) lost all the gains it had managed to make in the previous session before it had even made it halfway through the day. What gives? Well, to answer that question,&#46;&#46;&#46;<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[1585],"class_list":["post-6915","post","type-post","status-publish","format-standard","hentry","category-news","tag-tpiv"],"_links":{"self":[{"href":"https:\/\/articles.thehotpennystocks.com\/articles\/wp-json\/wp\/v2\/posts\/6915","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/articles.thehotpennystocks.com\/articles\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/articles.thehotpennystocks.com\/articles\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/articles.thehotpennystocks.com\/articles\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/articles.thehotpennystocks.com\/articles\/wp-json\/wp\/v2\/comments?post=6915"}],"version-history":[{"count":0,"href":"https:\/\/articles.thehotpennystocks.com\/articles\/wp-json\/wp\/v2\/posts\/6915\/revisions"}],"wp:attachment":[{"href":"https:\/\/articles.thehotpennystocks.com\/articles\/wp-json\/wp\/v2\/media?parent=6915"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/articles.thehotpennystocks.com\/articles\/wp-json\/wp\/v2\/categories?post=6915"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/articles.thehotpennystocks.com\/articles\/wp-json\/wp\/v2\/tags?post=6915"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}